Back to Search
Nextstellis (Nda 214154)
by Mayne PharmaContraceptionCOCP
Actively PrescribedReference Drug

Estrogen

Estetrol

14.2Mg

Progestin

Drospirenone

3Mg

Regimen Protocol

Monophasic 21 day

Androgenicity

Anti-androgenic (or neutral)

Additives
None
Inactive Ingredients
lactose monohydratecorn starchtitanium dioxidemagnesium stearatepovidonesodium starch glycolatehydrogenated cottonseed oilhydroxypropyl cellulosehypromelloseiron oxide redtalc

Contains common allergens

No active alternative brands identified

Have clinical questions about Nextstellis (Nda 214154)?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy